Patents by Inventor Bob M. Moore

Bob M. Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080234293
    Abstract: Cannabinoid derivatives according to formula (I) are disclosed wherein, X, Y, R1, R2, and W can have the definitions provided herein. Without limitation, use of such compounds, their salts or pro-drug, or compositions containing the compounds, salts, or pro-drug, to modify the activity of CB1 and CB2 receptors and treat conditions mediated by these receptors.
    Type: Application
    Filed: March 3, 2008
    Publication date: September 25, 2008
    Inventors: Bob M. Moore, Himanshu Bhattacharjee, Charles R. Yates, Leslie Stuart
  • Publication number: 20040242593
    Abstract: 1′-substituted cannabinoid derivatives of delta-8-tetrahydrocannabinol, delta-9-tetrahydrocannabinol, and delta-6a-10a-tetrahydrocannabinol that have affinity for the cannabinoid receptor type-1 (CB-1) and/or cannabinoid receptor type-2 (CB-2). Compounds having activity as either agonists or antagonists of the CB-1 and/or CB-2 receptors can be used for treating CB-1 or CB-2 mediated conditions.
    Type: Application
    Filed: May 20, 2004
    Publication date: December 2, 2004
    Inventors: Bob M. Moore, Antonio M. Ferreira, Mathangi Krishnamurthy
  • Publication number: 20040229928
    Abstract: Methods and kits for regulating arterial microvascular tone in which a COX-2 inhibitor and a cannabinoid receptor agonist are co-administered to a subject.
    Type: Application
    Filed: May 12, 2003
    Publication date: November 18, 2004
    Inventor: Bob M. Moore
  • Publication number: 20040229850
    Abstract: Methods and kits for regulating arterial microvascular tone in which a COX-2 inhibitor and a cannabinoid receptor agonist are co-administered to a subject.
    Type: Application
    Filed: April 12, 2004
    Publication date: November 18, 2004
    Inventor: Bob M. Moore
  • Publication number: 20040202735
    Abstract: Methods and kits for controlling bleeding from a disrupted blood vessel, wherein a vanilloid receptor agonist is administered to the site of the disruption of the blood vessel in a quantity sufficient to control the bleeding.
    Type: Application
    Filed: April 8, 2003
    Publication date: October 14, 2004
    Inventors: Bob M. Moore, Duane D. Miller
  • Publication number: 20040157871
    Abstract: The present invention relates to yohimbine dimer compounds, pharmaceutical compositions containing such dimer compounds, methods of making such dimer compounds, and uses thereof.
    Type: Application
    Filed: October 6, 2003
    Publication date: August 12, 2004
    Inventors: Duane D. Miller, Weiping Zheng, Bob M. Moore, Suni Mustafa, Dennis Rudolph Feller, Longping Lei, Shilpa G. Lalchandani
  • Publication number: 20030119791
    Abstract: The present invention relates to pharmacologically active compounds which are capable of binding to nuclear hormone receptors and are useful for the stimulation of osteoblast proliferation and ultimately bone growth. This invention also relates to the use of such compounds for the treatment or prevention of diseases and/or disorders associated with nuclear hormone receptor families.
    Type: Application
    Filed: March 27, 2002
    Publication date: June 26, 2003
    Inventors: Sean M. Kerwin, Laurence H. Hurley, Mark R. DeLuca, Bob M. Moore, Gregory R. Mundy
  • Publication number: 20030036547
    Abstract: The present invention relates to yohimbine dimer compounds, pharmaceutical compositions containing such dimer compounds, methods of making such dimer compounds, and uses thereof.
    Type: Application
    Filed: March 25, 2002
    Publication date: February 20, 2003
    Inventors: Duane D. Miller, Weiping Zheng, Bob M. Moore, Suni Mustafa